Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Hillery N, Seifert M, Catanzaro DG, McKinnon S, Colman RE, Chiles PG, Chesov D, Ciobanu N, Hagan C, Crudu V, Catanzaro A, Rodwell TC
Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Design of a field trial to develop a tabletop platform for rapid detection of XDR-TB in clinical samples
Naomi Hillery;
Marva Seifert;
Donald G Catanzaro;
Symone McKinnon;
Rebecca E Colman;
Peter G Chiles;
Dumitru Chesov;
Nelly Ciobanu;
Christopher Hagan;
Valeriu Crudu;
Antonino Catanzaro;
Timothy C Rodwell
ABSTRACT
Background:
Extensively drug-resistant tuberculosis (XDR-TB) continues to be a serious threat to global public health, due in part to the lack of accurate and efficient diagnostic devices for XDR-TB. A prospective clinical study in an intended-use cohort was designed to evaluate the Akonni Biosystems XDR-TB TruArray® and Lateral Flow Cell (XDR-LFC), which has the potential to address this gap in TB diagnostics.
Objective:
The objective of this publication is to share documentation of the study conceptualization and design that is replicable and of use to the scientific community.
Methods:
This clinical study was conducted in three phases, the first to observe changes in bacterial load and culture positivity in patient sputa over time and better understand the diversity of prospective clinical samples, the second to prospectively collect clinical samples for sensitivity and specificity testing of the Akonni Biosystems XDR-LFC device, and the third to explore anti-TB drug concentrations in serum over the course of DR-TB treatment.
Results:
The methodology described includes the study design, laboratory sample handling, data collection, and human subjects protection elements of the clinical study to evaluate a potential new XDR-TB diagnostic device. The complex systems implemented facilitated thorough clinical data collection for objective evaluation of the device. This trial is closed to recruitment. Follow-up data collection and analysis are in progress.
Conclusions:
This publication outlined the methods used in a prospective cohort study to evaluate a device to rapidly detect XDR-TB. The documentation of this clinical study design may be of use to other researchers with similar goals.
Citation
Please cite as:
Hillery N, Seifert M, Catanzaro DG, McKinnon S, Colman RE, Chiles PG, Chesov D, Ciobanu N, Hagan C, Crudu V, Catanzaro A, Rodwell TC
Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study